Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Shepherd

Showing results (951-960 of 1,281) with videos related to

Pageof 129
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2022
Single-Cell Analysis Reveals Transcriptomic Features of Drug-Tolerant Persisters and Stromal Adaptation in a Patient-Derived EGFR-Mutated Lung Adenocarcinoma Xenograft ModelNadeem Moghal, Quan Li, Erin L Stewart, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2004
Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage IIIA (T1-3, N2) unresectable non-small-cell lung cancer: final results of the Toronto phase II trialRonald L Burkes, Frances A Shepherd, Martin E Blackstein, et al.
Lung Cancer (Amsterdam, Netherlands)|April 7, 2006
Phase II study of pegylated liposomal doxorubicin HCl (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancerNatasha B Leighl, G D Goss, P G Lopez, et al.
Oncotarget|March 7, 2018
Differentially expressed microRNAs in lung adenocarcinoma invert effects of copy number aberrations of prognostic genesTomas Tokar, Chiara Pastrello, Varune R Ramnarine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2015
Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancerC Lim, M S Tsao, L W Le, et al.
JAMA Internal Medicine|September 28, 2020
Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity: The TREAT Randomized Clinical TrialDylan A Lowe, Nancy Wu, Linnea Rohdin-Bibby, et al.
Translational Lung Cancer Research|March 15, 2021
Prognostic and predictive effect of <i>KRAS</i> gene copy number and mutation status in early stage non-small cell lung cancer patientsAndrea S Fung, Maryam Karimi, Stefan Michiels, et al.
Pharmacoeconomics - Open|February 22, 2023
Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung CancerAndre Verhoek, Parneet Cheema, Barbara Melosky, et al.
NPJ Microgravity|June 24, 2024
Evaluation of body shape as a human body composition assessment in isolated conditions and remote environmentsMichael C Wong, Jonathan P Bennett, Lambert T Leong, et al.
Expert Review of Gastroenterology & Hepatology|September 13, 2024
Esophageal lymphocytosis: exploring the knowns and unknowns of this pattern of esophageal injuryLaoise C Coady, Kieran Sheahan, Ian S Brown, et al.
Pageof 129

Showing results (951-960 of 1,281) with videos related to

Sort By:
Pageof 129
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2022
Single-Cell Analysis Reveals Transcriptomic Features of Drug-Tolerant Persisters and Stromal Adaptation in a Patient-Derived EGFR-Mutated Lung Adenocarcinoma Xenograft ModelNadeem Moghal, Quan Li, Erin L Stewart, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2004
Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage IIIA (T1-3, N2) unresectable non-small-cell lung cancer: final results of the Toronto phase II trialRonald L Burkes, Frances A Shepherd, Martin E Blackstein, et al.
Lung Cancer (Amsterdam, Netherlands)|April 7, 2006
Phase II study of pegylated liposomal doxorubicin HCl (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancerNatasha B Leighl, G D Goss, P G Lopez, et al.
Oncotarget|March 7, 2018
Differentially expressed microRNAs in lung adenocarcinoma invert effects of copy number aberrations of prognostic genesTomas Tokar, Chiara Pastrello, Varune R Ramnarine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2015
Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancerC Lim, M S Tsao, L W Le, et al.
JAMA Internal Medicine|September 28, 2020
Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity: The TREAT Randomized Clinical TrialDylan A Lowe, Nancy Wu, Linnea Rohdin-Bibby, et al.
Translational Lung Cancer Research|March 15, 2021
Prognostic and predictive effect of <i>KRAS</i> gene copy number and mutation status in early stage non-small cell lung cancer patientsAndrea S Fung, Maryam Karimi, Stefan Michiels, et al.
Pharmacoeconomics - Open|February 22, 2023
Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung CancerAndre Verhoek, Parneet Cheema, Barbara Melosky, et al.
NPJ Microgravity|June 24, 2024
Evaluation of body shape as a human body composition assessment in isolated conditions and remote environmentsMichael C Wong, Jonathan P Bennett, Lambert T Leong, et al.
Expert Review of Gastroenterology & Hepatology|September 13, 2024
Esophageal lymphocytosis: exploring the knowns and unknowns of this pattern of esophageal injuryLaoise C Coady, Kieran Sheahan, Ian S Brown, et al.
Pageof 129